The collaboration is supported by a Wallonia (BioWin) research grant that was announced in April 2007. Financial details of the agreement have not been disclosed.
Jim DiGuiseppi, chief technology officer of OncoMethylome, said: “We look forward to using our high-throughput platform to efficiently test our portfolio of methylation biomarkers on clinical samples provided by GSK Biologicals. We are pleased that GSK Biologicals has chosen OncoMethylome for this collaboration.”